BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34678077)

  • 21. Long-term Change in the Risk of Skin Cancer After Organ Transplantation: A Population-Based Nationwide Cohort Study.
    Rizvi SMH; Aagnes B; Holdaas H; Gude E; Boberg KM; Bjørtuft Ø; Helsing P; Leivestad T; Møller B; Gjersvik P
    JAMA Dermatol; 2017 Dec; 153(12):1270-1277. PubMed ID: 29049612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of Sirolimus Use With Risk for Skin Cancer in a Mixed-Organ Cohort of Solid-Organ Transplant Recipients With a History of Cancer.
    Karia PS; Azzi JR; Heher EC; Hills VM; Schmults CD
    JAMA Dermatol; 2016 May; 152(5):533-40. PubMed ID: 26792250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. De novo cancers arising in organ transplant recipients are associated with adverse outcomes compared with the general population.
    Miao Y; Everly JJ; Gross TG; Tevar AD; First MR; Alloway RR; Woodle ES
    Transplantation; 2009 May; 87(9):1347-59. PubMed ID: 19424035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overall and cause-specific mortality in transplant recipients with a pretransplantation cancer history.
    Brattström C; Granath F; Edgren G; Smedby KE; Wilczek HE
    Transplantation; 2013 Aug; 96(3):297-305. PubMed ID: 23759880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in Skin Cancer Rates by Transplanted Organ Type and Patient Age After Organ Transplant in White Patients.
    Wheless L; Anand N; Hanlon A; Chren MM
    JAMA Dermatol; 2022 Nov; 158(11):1287-1292. PubMed ID: 36169974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recipient donor sex combinations in solid organ transplantation and impact on clinical outcome: A scoping review.
    Magyar CTJ; Gretener CP; Baldi P; Storni F; Kim-Fuchs C; Candinas D; Berzigotti A; Knecht M; Beldi G; Hirzel C; Sidler D; Reineke D; Banz V
    Clin Transplant; 2024 May; 38(5):e15312. PubMed ID: 38678586
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Declining incidence of keratinocyte carcinoma in organ transplant recipients.
    Menzies S; O'Leary E; Callaghan G; Galligan M; Deady S; Gadallah B; Lenane P; Lally A; Houlihan DD; Morris PG; Sexton DJ; McCormick PA; Egan JJ; O'Neill JP; Conlon PJ; Moloney FJ
    Br J Dermatol; 2019 Nov; 181(5):983-991. PubMed ID: 31049932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study.
    Chan AW; Fung K; Austin PC; Kim SJ; Singer LG; Baxter NN; Alhusayen R; Rochon PA
    Am J Transplant; 2019 Feb; 19(2):522-531. PubMed ID: 29900669
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Melanoma Risk and Survival among Organ Transplant Recipients.
    Robbins HA; Clarke CA; Arron ST; Tatalovich Z; Kahn AR; Hernandez BY; Paddock L; Yanik EL; Lynch CF; Kasiske BL; Snyder J; Engels EA
    J Invest Dermatol; 2015 Nov; 135(11):2657-2665. PubMed ID: 26270022
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rationale and design of TransplantLines: a prospective cohort study and biobank of solid organ transplant recipients.
    Eisenga MF; Gomes-Neto AW; van Londen M; Ziengs AL; Douwes RM; Stam SP; Osté MCJ; Knobbe TJ; Hessels NR; Buunk AM; Annema C; Siebelink MJ; Racz E; Spikman JM; Bodewes FAJA; Pol RA; Berger SP; Drost G; Porte RJ; Leuvenink HGD; Damman K; Verschuuren EAM; de Meijer VE; Blokzijl H; Bakker SJL
    BMJ Open; 2018 Dec; 8(12):e024502. PubMed ID: 30598488
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Spectrum of De Novo Cancers and Predictors in Liver Transplantation: Analysis of the Scientific Registry of Transplant Recipients Database.
    Zhou J; Hu Z; Zhang Q; Li Z; Xiang J; Yan S; Wu J; Zhang M; Zheng S
    PLoS One; 2016; 11(5):e0155179. PubMed ID: 27171501
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of new-onset diabetes mellitus and association with mortality in childhood solid organ transplant recipients: a population-based study.
    Chanchlani R; Kim SJ; Dixon SN; Jassal V; Banh T; Borges K; Vasilevska-Ristovska J; Paterson JM; Ng V; Dipchand A; Solomon M; Hebert D; Parekh RS
    Nephrol Dial Transplant; 2019 Mar; 34(3):524-531. PubMed ID: 30060206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer survival in kidney transplant recipients in Ireland.
    Murray SL; O'Leary E; De Bhailís ÁM; Deady S; Daly FE; O'Kelly P; Williams Y; O'Neill JP; Sexton DJ; Conlon PJ
    Nephrol Dial Transplant; 2020 Oct; 35(10):1802-1810. PubMed ID: 32638007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Underweight Patients With Cystic Fibrosis Have Acceptable Survival Following Lung Transplantation: A United Network for Organ Sharing Registry Study.
    Ramos KJ; Kapnadak SG; Bradford MC; Somayaji R; Morrell ED; Pilewski JM; Lease ED; Mulligan MS; Aitken ML; Gries CJ; Goss CH
    Chest; 2020 Apr; 157(4):898-906. PubMed ID: 31958441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of All-Cause Mortality Between Canadian Kidney Transplant Recipients and Patients With Cancer: A Population-Based Cohort Study.
    Naylor KL; Kim SJ; McArthur E; Garg AX; Vinegar M; McCallum MK; Knoll GA
    Can J Kidney Health Dis; 2021; 8():20543581211056234. PubMed ID: 34777844
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of lung allocation score on survival in cystic fibrosis lung transplant recipients.
    Braun AT; Dasenbrook EC; Shah AS; Orens JB; Merlo CA
    J Heart Lung Transplant; 2015 Nov; 34(11):1436-41. PubMed ID: 26212659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The association between severe or death COVID-19 and solid organ transplantation: A systematic review and meta-analysis.
    Ao G; Wang Y; Qi X; Nasr B; Bao M; Gao M; Sun Y; Xie D
    Transplant Rev (Orlando); 2021 Jul; 35(3):100628. PubMed ID: 34087553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes.
    DuBay DA; MacLennan PA; Reed RD; Shelton BA; Redden DT; Fouad M; Martin MY; Gray SH; White JA; Eckhoff DE; Locke JE
    J Am Coll Surg; 2016 Oct; 223(4):611-620.e4. PubMed ID: 27457252
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of Colorectal Cancer After Solid Organ Transplantation in the United States.
    Safaeian M; Robbins HA; Berndt SI; Lynch CF; Fraumeni JF; Engels EA
    Am J Transplant; 2016 Mar; 16(3):960-7. PubMed ID: 26731613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Outcomes in solid organ transplant recipients with a pretransplant diagnosis of melanoma.
    Zwald FO; Sargen MR; Austin AA; Hsieh MC; Pawlish K; Li J; Lynch CF; Yu KJ; Engels EA
    Am J Transplant; 2024 Jun; 24(6):993-1002. PubMed ID: 38387619
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.